The global Activin Receptor Type 1 market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Activin Receptor Type 1 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Activin Receptor Type 1 market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Activin Receptor Type 1 in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Activin Receptor Type 1 manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Blueprint Medicines Corp
Daiichi Sankyo Company Ltd
La Jolla Pharmaceutical Company
Oncodesign SA
Tolero Pharmaceuticals Inc
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
LJPC-6417
TP-0184
Dipyridamole
Others

Segment by Application
Alport Syndrome
Chronic Kidney Disease
Kidney Fibrosis
Obesity
Others